790 related articles for article (PubMed ID: 25434980)
41. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
42. [Detection of contralateral axillary sentinel lymph node by lymphoscintigraphy in breast cancer: prognostic implications].
Luján B; Carrera D; Picas J; Izquierdo V; Siurana R; Quintero L; Martínez de Vírgala C
Rev Esp Med Nucl; 2010; 29(3):135-7. PubMed ID: 20398968
[TBL] [Abstract][Full Text] [Related]
43. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
44. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
45. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
46. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
[TBL] [Abstract][Full Text] [Related]
47. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
48. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
[TBL] [Abstract][Full Text] [Related]
49. Mammary lymphoscintigraphy in breast cancer.
Uren RF; Howman-Giles RB; Thompson JF; Malouf D; Ramsey-Stewart G; Niesche FW; Renwick SB
J Nucl Med; 1995 Oct; 36(10):1775-80. PubMed ID: 7562041
[TBL] [Abstract][Full Text] [Related]
50. [Sentinel node in melanoma and breast cancer. Current considerations].
Vidal-Sicart S; Vilalta Solsona A; Alonso Vargas MI
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):30-44. PubMed ID: 25455506
[TBL] [Abstract][Full Text] [Related]
51. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
[TBL] [Abstract][Full Text] [Related]
52. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
[TBL] [Abstract][Full Text] [Related]
53. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
[TBL] [Abstract][Full Text] [Related]
54. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
[TBL] [Abstract][Full Text] [Related]
55. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
56. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
Alkuwari E; Auger M
Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
[TBL] [Abstract][Full Text] [Related]
57. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
[TBL] [Abstract][Full Text] [Related]
58. Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer.
Seok JW; Kim IJ; Heo YJ; Yang YJ; Choi YS; Kim BG; Park SJ
Ann Nucl Med; 2009 Jul; 23(5):465-9. PubMed ID: 19452250
[TBL] [Abstract][Full Text] [Related]
59. Preoperative lymphoscintigraphy and tumor histologic grade are associated with surgical detection of the sentinel lymph node.
Arias Ortega M; Torres Sousa MY; González García B; Pardo García R; González López A; Delgado Portela M
Radiologia; 2014; 56(6):515-23. PubMed ID: 23489766
[TBL] [Abstract][Full Text] [Related]
60. Internal mammary lymph node metastases in breast cancer: what should radiologists know?
Urano M; Denewar FA; Murai T; Mizutani M; Kitase M; Ohashi K; Shiraki N; Shibamoto Y
Jpn J Radiol; 2018 Nov; 36(11):629-640. PubMed ID: 30194586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
